Details

Autor(en) / Beteiligte

• Facchinetti, Fabio, MD
• Marozio, Luca, MD, PhD
• Frusca, Tiziana, MD
• Grandone, Elvira, MD
• Venturini, Paolo, MD
• Tiscia, Giovanni Luca, MD
• Zatti, Sonia, MD
• Benedetto, Chiara, MD, PhD

Titel

Maternal thrombophilia and the risk of recurrence of preeclampsia

Ist Teil von

• American journal of obstetrics and gynecology, 2009, Vol.200 (1), p.46.e1-46.e5

Ort / Verlag

New York, NY: Mosby, Inc

Erscheinungsjahr

2009

Quelle

MEDLINE

Beschreibungen/Notizen

• Objective The aim of this prospective study was to determine the impact of thrombophilia on the recurrence of preeclampsia. Study Design In a multicenter, observational, cohort design, 172 white patients with a previous pregnancy complicated by preeclampsia were observed in the next pregnancy. They were evaluated for heritable thrombophilia (factor V Leiden and factor II G20210A mutations, protein S, protein C, and antithrombin deficiency), hyperhomocystinemia, lupus anticoagulant, and anticardiolipin antibodies. Development of preeclampsia and maternal complications and both gestational age at delivery and birthweight were recorded. Results Sixty women (34.9%) showed the presence of a thrombophilic defect. They had a higher risk for the recurrence of preeclampsia (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.2-5.1), compared to patients without thrombophilia. Similar findings were observed considering only heritable thrombophilia. Thrombophilic patients were at increased risk for the occurrence of very early preterm delivery (< 32 weeks; OR, 11.6; 95% CI, 3.4-43.2). Conclusion When counseling white women with a history of preeclampsia, screening for thrombophilia can be useful for preconceptional counseling and pregnancy management.